72516-016-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Oryza Pharmaceuticals Inc.
What is the status for 72516-016-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Oryza Pharmaceuticals Inc.?
For 72516-016-01, generic name is Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet; manufacturer is Oryza Pharmaceuticals Inc; status is Current; availability now is Unavailable; fda note is Estimated recovery: April 2027, recorded from its source on 2026-11-04.
"initial_posting_date": "10/12/2022", "package_ndc": "72516-016-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated recovery: April 2027"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 72516-016-01 verified
- Generic name
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet verified
- Manufacturer
- Oryza Pharmaceuticals Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Estimated recovery: April 2027 verified
- Initial posting date
- 10/12/2022 verified
- Last update date
- 10/15/2026 verified
- Days in shortage
- 1484 our reading
- Reason for shortage
- Shortage of an active ingredient verified
- Dosage form
- Tablet verified
- Therapeutic category
- Psychiatry verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "10/15/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000